In a recent study, we performed targeted gene expression profiling of ACC tumour samples and identified up-regulated genes and pathways, including cyclin-dependent kinase (CDK) and polo-like kinase (PLK) families (9), whose inhibition may represent promising treatment options. This evidence concerns the gene PLK1 and adrenal cortex carcinoma.